Tocagen Inc Has Secured Orphan Drug Status For Its Investigational Gene Therapy Treatment For Glioblastoma
It Follows Hard On The Heels Of The Combination Treatment Toca 511 & Toca Fc Winning Fast Track Designation Just Last Month Assisting The Company In Its Quest To Further Advance The Drug'S Development.Glioblastoma Is The Most Common Type Of Brain Cancer, And Most Aggressive, With More Than 10,000 New Cases Every Year In The United States. However Once Diagnosed, Patients Have A Five-Year Survival Rate Of Less Than 5%.Harry Gruber, Ceo Of Tocagen, Said:
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
